DelveInsight Evaluates a Robust Waldenstrom's Macroglobulinemia Pipeline as 20+ Influential Pharma Players to Set Foot in the Domain

MLA

“DelveInsight Evaluates a Robust Waldenstrom’s Macroglobulinemia Pipeline as 20+ Influential Pharma Players to Set Foot in the Domain.” GlobeNewswire, 24 Apr. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.746799380&authtype=sso&custid=ns315887.

APA

DelveInsight Evaluates a Robust Waldenstrom’s Macroglobulinemia Pipeline as 20+ Influential Pharma Players to Set Foot in the Domain. (2023, April 24). GlobeNewswire.

Chicago

GlobeNewswire. 2023. “DelveInsight Evaluates a Robust Waldenstrom’s Macroglobulinemia Pipeline as 20+ Influential Pharma Players to Set Foot in the Domain,” April 24. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.746799380&authtype=sso&custid=ns315887.